You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cutaneous manifestations

Showing 1 - 25 of 2,862
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Evaluation and Treatment of Patients With Dermatologic Diseases

Recruiting
  • Dermatologic Diseases
  • Systemic Diseases With Cutaneous Manifestations
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous Trial (Placebo, PF-06823859)

    Not yet recruiting
    • Lupus Erythematosus, Systemic
    • Lupus Erythematosus, Cutaneous
    • (no location specified)
    May 18, 2023

    Cutaneous Manifestations, Skin Manifestations, COVID-19 Trial in Karachi

    Completed
    • Cutaneous Manifestations
    • +7 more
      • Karachi, Sindh, Pakistan
        Jinnah Postgraduate Medical Centre
      Nov 12, 2021

      Lupus Erythematosus, Cutaneous, Subacute, Chronic Cutaneous Lupus Erythematosus Trial (BIIB059 (litifilimab))

      Not yet recruiting
      • Lupus Erythematosus, Cutaneous, Subacute
      • Chronic Cutaneous Lupus Erythematosus
      • BIIB059 (litifilimab)
      • (no location specified)
      Sep 12, 2023

      Dermatomyositis, Juvenile Dermatomyositis Trial in Cleveland (H.P. Acthar Gel)

      Completed
      • Dermatomyositis
      • Juvenile Dermatomyositis
      • H.P. Acthar Gel
      • Cleveland, Ohio
        Cleveland Clinic
      Sep 10, 2021

      Chronic Kidney Diseases, Manifestation, Skin Trial (observe pattern of mucocutaneous manifestations in chronic kidney disease

      Not yet recruiting
      • Chronic Kidney Diseases
      • Manifestation, Skin
      • observe pattern of mucocutaneous manifestations in chronic kidney disease patients
      • (no location specified)
      Apr 6, 2023

      Dermatomyositis Trial in Nanchang (Lenalidomide)

      Not yet recruiting
      • Dermatomyositis
      • Nanchang, Jiangxi, China
        Department of Rheumatology and Clinical Immunology, Jiangxi Prov
      Aug 3, 2022

      Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

      Recruiting
      • Cryoglobulinemic Vasculitis (CV)
      • +9 more
        • Los Angeles, California
        • +7 more
        Jan 12, 2023

        Prevelance Of Cutaneous Disorders Among Heamatologic

        Not yet recruiting
        • Dermatologic Disorders With Heamatologic Malignancies Patients
        • cbc ,u\s renalor hepatic function test if needed
        • Sohag, Egypt
          Sohag university Hospital
        Oct 25, 2023

        Mast Cell Activation Disease, Mast Cell Activation Syndrome, Mast Cell Disease Trial in Poitiers (Ophthalmological examination)

        Recruiting
        • Mast Cell Activation Disease
        • +3 more
        • Ophthalmological examination
        • Poitiers, Nouvelle Aquitaine, France
          Masson Regnault
        Apr 12, 2022

        Inflammatory Bowel Disease Related Joint Manifestations

        Not yet recruiting
        • IBD
        • Joint Diseases
          • (no location specified)
          Jan 12, 2023

          The Clinical Manifestations of Severe Acute Respiratory

          Completed
          • Covid19
            • Assiut, Egypt
              Assiut University Hospital
            Jun 5, 2022

            Dermatology Trial in Bologna (Neoviderm Skin Emulsion medical device, Connettivina 0.2% Cream)

            Not yet recruiting
            • Dermatology
            • Neoviderm Skin Emulsion medical device
            • Connettivina 0.2% Cream
            • Bologna, Italy
              UO Dermatologia - Piraccini IRCCS Azienda Ospedaliero-Universita
            Apr 6, 2023

            Discoid Lupus Erythematosus Trial in Cairo (Nicotinamide Topical)

            Completed
            • Discoid Lupus Erythematosus
            • Nicotinamide Topical
            • Cairo, Egypt
              AL-Azhar University Hospital
            Oct 22, 2022

            Cutaneous Lupus Erythematosus Trial (Anifrolumab, Placebo)

            Not yet recruiting
            • Cutaneous Lupus Erythematosus
            • Anifrolumab
            • Placebo
            • (no location specified)
            Aug 22, 2023

            Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial in New York (UVADEX® (methoxsalen) Sterile Solution in conjunction with the

            Recruiting
            • Cutaneous T Cell Lymphoma
            • Mycosis Fungoides
            • UVADEX® (methoxsalen) Sterile Solution in conjunction with the UVAR® THERAKOS® CELLEX Photopheresis
            • THERAKOS® CELLEX photopheresis system
            • New York, New York
              Herbert Irving Pavilion
            Dec 23, 2022

            Skin Disease in Methamphetamine Abuse

            Not yet recruiting
            • Methamphetamine Abuse
              • (no location specified)
              Jul 31, 2023

              Cutaneous Warts Trial (Hepatitis B Virus Vaccine(HBV))

              Not yet recruiting
              • Cutaneous Warts
              • Hepatitis B Virus Vaccine(HBV)
              • (no location specified)
              Jun 13, 2023

              Skin Manifestations Associated With Adhesives in Diabetes

              Completed
              • Diabetes
              • CUTADIAB questionnaire
              • Paris, France
              • +3 more
              Feb 2, 2023

              Neurocutaneous Syndromes in Upper Egypt Children

              Not yet recruiting
              • Neurocutaneous Syndromes
                • (no location specified)
                Sep 10, 2023

                Systemic Lupus Erythematosus, Active Cutaneous Lupus Erythematosus Trial in Worldwide (BIIB059, Placebo)

                Completed
                • Systemic Lupus Erythematosus
                • Active Cutaneous Lupus Erythematosus
                • Anniston, Alabama
                • +128 more
                Aug 27, 2020

                Leishmaniasis Trial in Beer Sheva (Topical Amphotericin-B 0.4% liposomal gel)

                Completed
                • Leishmaniasis
                • Topical Amphotericin-B 0.4% liposomal gel
                • Beer Sheva, Israel
                  Soroka University Medical Center
                Mar 12, 2022

                Angiofibroma of Face, Tuberous Sclerosis Trial in China, United States (Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment)

                Recruiting
                • Angiofibroma of Face
                • Tuberous Sclerosis
                • Sirolimus 0.2%
                • +2 more
                • Phoenix, Arizona
                • +7 more
                Feb 2, 2022

                Immunoclassification, Psoriasis Trial in Hangzhou (adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors,

                Recruiting
                • Immunoclassification
                • Psoriasis
                • adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate
                • Hangzhou, Zhejiang, China
                  2nd Affiliated Hospital, School of Medicine, Zhejiang University
                Aug 16, 2022

                Ocular, Periocular and Cutaneous Tolerance and Efficacy of

                Completed
                • Eczema Eyelid
                  • Batumi, Georgia
                  • +1 more
                  Sep 12, 2022